EUVIMEDEUVIMED entdecken
Crossref

The Effect of Lipoprotein(a) Levels on Non‐Culprit Atherosclerosis in Patients With Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention: An Optical Coherence Tomography Study

Yi-Fei Wang iD, Tian Xu, Wei You, Jia-Cong Nong, Pei-Na Meng, Xiang-Qi Wu, Zhi-Ming Wu, Feng-Wang, Fei Ye iD

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.31596 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Yi-Fei Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Lipoprotein(a), Acute Coronary Syndrome, Tomography, Optical Coherence. Die Arbeit nennt 41 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The association between lipoprotein(a) [Lp(a)] levels and progression of non‐culprit atherosclerosis (NSA) in patients with acute coronary syndrome (ACS) who underwent percutaneous coronary intervention (PCI) is unknown.

Methods

This study enrolled 177 patients with ACS who underwent OCT‐guided PCI and follow‐up OCT examinations of non‐culprit lesions between 2013 and 2018. Lesion characteristics including fibrous tissue, calcium, lipid, and macrophage content were assessed using quantitative plaque analysis. High Lp(a) levels were defined as Lp(a) ≥ 30 mg/dL. The association between Lp(a) levels and NSA progression was investigated using linear effect models adjusted for clinical risk factors. A discordance analysis was also performed.

Results

At 1‐year follow‐up, individuals with Lp(a) levels ≥ 30 mg/dL had increased total atheroma volume and lipid component, and higher incidence of thin‐cap fibroatheroma (TCFA) ( p = 0.021; p = 0.006; p = 0.025, respectively). After adjusted, multivariable linear regression model revealed an association between Lp(a) and plaque progression in NSA (7.22 for each 1 SD increase, 95% CI: 0.96–13.48; p = 0.025) and increased lipid component (3.60 for each 1 SD increase, 95% CI: 0.63–6.56; p = 0.019). Discordance analyses showed that individuals with discordantly low Lp(a) levels had the lightest plaque progression and increase in lipid plaque burden (17.34 [10.22, 28.21] vs. 28.73 [14.88, 45.88] versus 25.73 [13.85, 45.70], p = 0.017).

Conclusion

Among patients with ACS, elevated Lp(a) levels were related to the progression of coronary plaques in non‐culprit lesions, including increased total atheroma volume and lipid component, and a higher prevalence of TCFA at follow‐up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Percutaneous Coronary InterventionLipoprotein(a)Acute Coronary SyndromeTomography, Optical CoherencePlaque, AtheroscleroticCoronary Artery DiseaseCoronary VesselsHumansMaleFemaleMiddle AgedAgedBiomarkersDisease ProgressionPredictive Value of TestsTreatment OutcomeTime FactorsRisk FactorsUp-RegulationFibrosisRetrospective StudiesRisk Assessment

Stichwörter der Autor:innen

atherosclerosislipoprotein(a)non‐culprit lesionoptical coherence tomography

Substanzen

Lipoprotein(a)BiomarkersLPA protein, human

Autor:innen und Institutionen

  • Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.

ORCID-Profile: Yi-Fei Wang, Fei Ye

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Wang, Y. F., Xu, T., You, W., Nong, J. C., Meng, P. N., Wu, X. Q., Wu, Z. M., Feng-Wang, & Ye, F. (2025). The Effect of Lipoprotein(a) Levels on Non‐Culprit Atherosclerosis in Patients With Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention: An Optical Coherence Tomography Study. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31596

Vancouver

Wang YF, Xu T, You W, Nong JC, Meng PN, Wu XQ, et al. The Effect of Lipoprotein(a) Levels on Non‐Culprit Atherosclerosis in Patients With Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention: An Optical Coherence Tomography Study. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31596

BibTeX
@article{Wang2025,
  author = {Wang, Yi-Fei and Xu, Tian and You, Wei and Nong, Jia-Cong and Meng, Pei-Na and Wu, Xiang-Qi and Wu, Zhi-Ming and Feng-Wang and Ye, Fei},
  title = {The Effect of Lipoprotein(a) Levels on Non‐Culprit Atherosclerosis in Patients With Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention: An Optical Coherence Tomography Study},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.31596}
}
Kostenlos starten →